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Abstract
Background: Many pathogens secrete toxins that target key host processes resulting in the activation of immune
pathways. The secreted Pseudomonas aeruginosa toxin Exotoxin A (ToxA) disrupts intestinal protein synthesis, which
triggers the induction of a subset of P. aeruginosa-response genes in the nematode Caenorhabditis elegans.
Results: We show here that one ToxA-induced C. elegans gene, the Tribbles pseudokinase ortholog nipi-3, is essential
for host survival following exposure to P. aeruginosa or ToxA. We find that NIPI-3 mediates the post-developmental
expression of intestinal immune genes and proteins and primarily functions in parallel to known immune pathways,
including p38 MAPK signaling. Through mutagenesis screening, we identify mutants of the bZIP C/EBP transcription
factor cebp-1 that suppress the hypersusceptibility defects of nipi-3 mutants.
Conclusions: NIPI-3 is a negative regulator of CEBP-1, which in turn negatively regulates protective immune mechanisms.
This pathway represents a previously unknown innate immune signaling pathway in intestinal epithelial cells that
is involved in the surveillance of cellular homeostasis. Because NIPI-3 and CEBP-1 are also essential for C. elegans
development, NIPI-3 is analogous to other key innate immune signaling molecules such as the Toll receptors in
Drosophila that have an independent role during development.
See also companion paper by Kim et al. http://bmcbiol.biomedcentral.com/articles/10.1186/s12915-016-0320-z.
Keywords: Surveillance immunity, Tribbles-like kinase, C/EBP, Pseudomonas aeruginosa, Exotoxin A, Translational
inhibition, Caenorhabditis elegans, Innate epithelial immunity, Lifespan machine
Background
A fundamental problem for all multicellular animals is
that they must respond to invading pathogens while
simultaneously tolerating or facilitating the growth of
commensal microbes. Evidence has been mounting that
metazoans can recognize pathogens by detecting the
activity of so-called pathogen-encoded virulence effec-
tors [1]. Although significant advances have been made
in understanding how these immune triggers are sensed,
it is poorly understood how they activate the defense
responses that lead to the protection of host tissues from
pathogen-inflicted damage and ultimately to the reso-
lution of infection.
To investigate these issues, we study the nematode
Caenorhabditis elegans which, when exposed to human
pathogens, activates multiple discrete immune signaling
pathways including an evolutionary conserved p38 MAPK
pathway that is also critical for mammalian immunity [2].
For C. elegans infected with the gram-negative nosocomial
pathogen Pseudomonas aeruginosa, deployment of these
signaling pathways and resulting gene induction is directly
correlated with bacterial virulence [3, 4], leading us to
hypothesize that P. aeruginosa virulence factors may
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themselves trigger host immune gene expression. To test
this theory, in previously published work, we screened for
individual P. aeruginosa effectors that are capable of indu-
cing a host immune response and discovered that expos-
ure to Exotoxin A (ToxA) upregulates C. elegans immune
genes [5]. ToxA is an extremely potent toxin of the AB
class that inhibits protein translation by catalyzing the
ADP-ribosylation of elongation factor 2, the same reaction
catalyzed by diphtheria toxin from Corynebacterium
diphtheriae and cholix toxin from Vibrio cholerae [6, 7].
The high level of toxicity of these enzymes has enabled
their use as immunotoxins to treat a variety of cancers [8].
We determined that C. elegans recognizes ToxA inde-
pendently of ToxA per se by detecting its enzymatic
activity, translational inhibition [5]. Significantly, this im-
mune activation is independent of physical microbial fea-
tures called microbe- or pathogen-associated molecular
patterns (MAMPs/PAMPs) or pattern recognition recep-
tors, which are the traditionally studied mechanisms of
pathogen recognition. Dunbar et al. [9] similarly dis-
covered that inhibiting host translation stimulates the
MAMP/PAMP-independent upregulation of the C. elegans
ZIP-2 transcription factor resulting in zip-2-dependent
gene induction. Mammalian cells are also able to sense
pathogens by recognizing protein synthesis abnormalities;
translational inhibitors secreted by Legionella pneumo-
phila activate NF-κB and MAP kinase signaling and trig-
ger the transcription of their target genes [10, 11], a subset
of which are also upregulated at the protein level [12, 13].
Additional cellular processes commonly targeted by bac-
terial effectors are monitored through similar surveillance
mechanisms [1, 14]. While a commonality of all these
effector-triggered mechanisms is that they require either
injury or modification to the host, the host genetic circuits
that respond to these insults and act to protect against
subsequent effector-mediated damage are only beginning
to be understood. We therefore used the C. elegans/ToxA
system to identify and characterize new components of
surveillance signaling pathways.
Here, we investigate the genetic pathways that enable
nematodes to mitigate the damaging effects of ToxA-
mediated translational inhibition. Using an automated C.
elegans Lifespan Machine [15], we show that the C.
elegans nipi-3 gene is required for animals to survive
exposure to ToxA as well as to P. aeruginosa. NIPI-3 is
a member of the highly conserved, functionally diverse
Tribbles protein family, which, when mutated, has been
linked to a variety of disorders related to cell signaling,
immunity, metabolism, and cancer [16]. NIPI-3 has been
previously shown to function upstream of p38 MAPK in
the epidermis during fungal attacks [17] and, more re-
cently, it has been determined to be required in multiple
tissues during development (Kim et al. http://bmcbiol.
biomedcentral.com/articles/10.1186/s12915-016-0320-z).
Through partial loss-of-function and rescue studies, we
find here that the C. elegans immune response against
ToxA and P. aeruginosa is mediated in adult animals by
intestinal NIPI-3 which, in contrast to epidermal NIPI-3,
does not directly function in known C. elegans immune
pathways but instead represses the activity of the bZIP
C/EBP transcription factor CEBP-1.
Results
nipi-3 mutants are hypersusceptible to translational
inhibitors and Pseudomonas aeruginosa
We previously found that ToxA does not irreparably dam-
age healthy C. elegans as wild type animals have the same
longevity when feeding on an E. coli strain expressing P.
aeruginosa PA14 ToxA as on control bacteria [5]. However,
nematodes defective in immune signaling pathways, such
as the p38 MAPK pathway, die rapidly when fed ToxA E.
coli [5], implying that C. elegans normally resist this highly
toxic enzyme through an effective host defense. We rea-
soned that genes upregulated in response to ToxA might be
required to protect against or recover from toxin-induced
damage and allow wild type worms to survive. Through
genome-wide transcriptional profiling using Affymetrix
GeneChips©, we previously identified 144 genes that were
upregulated in wild type N2 C. elegans fed ToxA [5].
Using RNAi or mutant alleles corresponding to 125 of
the most highly upregulated genes (Additional file 1:
Table S1), we assayed for premature lethality in worms
fed ToxA and found that the nipi-3(fr4) mutant exhibited
the most significant reduction in lifespan (data not shown).
In our previous microarray analysis, nipi-3 was upregulated
4.3-fold in worms exposed to ToxA for 24 hours and was
one of the two most highly induced kinases [5]. Whereas
nipi-3 null mutants arrest by larval development stage
L3 (Kim et al. http://bmcbiol.biomedcentral.com/articles/
10.1186/s12915-016-0320-z), nipi-3(fr4) is a fully viable
hypomorphic allele, which, as described below, has
allowed us to selectively address NIPI-3’s role in pathogen
defense. nipi-3(fr4) contains a single mutation (I307N) in
a conserved residue in the kinase domain [17].
Using a C. elegans Lifespan Machine, a modified com-
mercial flatbed scanner in conjunction with automated
image analysis software [15], we analyzed the survival of
the nipi-3(fr4) mutant feeding on ToxA and found that
nipi-3(fr4) had a dramatically reduced lifespan on this
food compared to wild type animals (Fig. 1a; P < 0.0001).
Although nipi-3(fr4) has been reported to have a short-
ened lifespan [17], its longevity on ToxA was signifi-
cantly shorter than on a control, non-pathogenic BL21
E. coli strain (Additional file 2: Figure S1a; P < 0.001),
whereas the lifespans of wild type N2 worms on control
BL21 E. coli or on ToxA were equivalent (Additional file 2:
Figure S1a; P > 0.05) [5].
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We previously showed that C. elegans immune-related
signaling pathways, including the PMK-1 p38 MAPK
pathway, are activated by ToxA-mediated translational
inhibition rather than by ToxA itself. We therefore
tested whether nipi-3 mutants are also defective in their
response to the protein synthesis inhibitor G418. Similar
Fig. 1 nipi-3(fr4) mutants have reduced resistance to ToxA, G418 and Pseudomonas aeruginosa. a Lifespans of wild type N2, nipi-3(fr4), and three
independent lines of nipi-3(fr4) expressing wild type nipi-3p::nipi-3 fed E. coli expressing ToxA starting at the L4 stage. P < 0.0001 comparing nipi-3(fr4)
and wild type (log-rank test). b Fraction of synchronized L1 worms that grew to at least young adult stage after 3 days at 20 °C on plates containing
the indicated G418 concentration. Results shown are an average of four biological replicates. Error bars represent SD. *P < 0.05 compared to wild type
animals at the given concentration (Student’s unpaired t-test). c Lifespans of wild type N2, nipi-3(fr4), and nipi-3(fr4) expressing wild type nipi-3p::nipi-3
fed on P. aeruginosa PA14. nipi-3(fr4);agEx120(-) indicates non-transgenic offspring of nipi-3p::nipi-3 transgenic worms. P < 0.001 comparing nipi-3(fr4)
and wild type (log-rank test). Number of animals scored for each condition was ≥ 80 (547 total; a) and > 85 (487 total; c). These are representative
experiments of two independent experiments. Primary data for panel b are provided in Additional file 15
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to pmk-1 mutants, nipi-3(fr4) animals were more
sensitive to G418 than wild type animals, indicating that
nipi-3 protects the host against translational inhibition
and not an unrelated aspect of ToxA intoxication
(Fig. 1b). Finally, we reasoned that nipi-3 is likely to be
required for C. elegans defense against P. aeruginosa,
which produces ToxA. Indeed, nipi-3(fr4) mutants were
hypersusceptible to P. aeruginosa in large-lawn auto-
mated assays in which C. elegans animals were unable to
avoid being in contact with the bacterial lawn (Fig. 1c;
P < 0.001). Reintroduction of wild type nipi-3 expressed
by its own promoter rescued the hypersusceptibility of
nipi-3(fr4) to ToxA and P. aeruginosa (Fig. 1a, c).
To confirm that nipi-3(fr4) is not merely sensitive to
any stressor, but is distinctly susceptible to translational
inhibitors, we compared the ability of wild type and
nipi-3(fr4) worms to recover from prolonged develop-
mental arrest. Animals were arrested at the first larval
stage and then starved for up to 14 days (L1 arrest or L1
diapause). Longer starvation reduces the number of
animals that can recover upon feeding and grow to adults.
Escaping this starvation-induced arrest requires the coord-
ination of multiple pathways, including those required for
general lifespan and stress responses [18]. In this assay,
nipi-3(fr4) recovery was equivalent to wild type (Additional
file 2: Figure S1b), indicating that nipi-3(fr4) is not broadly
susceptible to any stressful condition.
Immune genes are misregulated in nipi-3(fr4) mutants
We previously found that ToxA-sensitive mutants, such as
pmk-1(km25), misregulate pathogen-responsive genes [5],
suggesting that nipi-3(fr4) animals will show similar tran-
scriptional defects. However, unlike for pmk-1, complete
loss of nipi-3 function causes animals to arrest at the L2/L3
larval stage (Kim et al. http://bmcbiol.biomedcentral.com/
articles/10.1186/s12915-016-0320-z) indicating that nipi-3
is critical to both development and immunity. Thus, to
understand the potential relationship between these
processes and to dissect apart nipi-3’s apparent roles in
both development and immunity, we performed genome-
wide transcriptional profiling assays using Affymetrix Gene-
Chips® comparing wild type, nipi-3(fr4), and pmk-1(km25)
animals that were fed control OP50 E. coli. Surprisingly, we
found that a large number of genes were significantly up-
regulated in nipi-3(fr4) mutants: 282 genes were upregu-
lated in nipi-3(fr4), whereas, for comparison, only 8 genes
were induced in pmk-1(km25) (Additional file 3: Table S2).
Gene ontology (GO) term analysis showed that transcripts
upregulated in nipi-3 mutants were enriched for processes
involved in immunity, similar to the GO terms enriched
among the 43 genes downregulated in pmk-1(km25) ani-
mals (Additional file 3: Table S2), suggesting nipi-3 may be
a negative immune regulator. The only other overrepre-
sented GO terms among the nipi-3(fr4)-upregulated genes
involved flavonoid processes (Additional file 3: Table S2)
due to the presence of 9 UDP-glucuronosyltransferases
which, in addition to modifying flavonoids in plants,
metabolize and detoxify xenobiotic compounds in meta-
zoans [19, 20]. There were no enriched GO categories for
the 71 genes downregulated in nipi-3(fr4) or the 8 genes
upregulated in pmk-1(km25) animals. These gene expres-
sion results indicate that, similar to pmk-1(km25), the nipi-
3(fr4) allele is specifically defective in immune processes
and that we can use nipi-3(fr4) to study the role of nipi-3 in
pathogen defense separately from its role in development.
To expand on the microarray results and test the
effect of nipi-3(fr4) on immune gene expression under
different conditions, we utilized a NanoString© codeset
containing 118 C. elegans genes involved in immune-
and stress-related responses (Additional file 4: Table S3).
NanoString analysis recapitulated the microarray gene
expression changes observed between wild type and
nipi-3 mutant animals under normal growth conditions.
We confirmed that 26 of the 27 codeset genes predicted
to be nipi-3-dependent from the microarray data were
similarly affected in the NanoString analysis; the
remaining gene was upregulated 1.9× (false discovery rate
(FDR) < 1 × 10–2), falling just below the two-fold cutoff.
An additional 13 NanoString codeset genes that were not
identified as being differentially regulated by microarray
analysis were also statistically significantly up- or down-
regulated in nipi-3(fr4), suggesting that the microarray
analysis is either less sensitive or more stringent than
NanoString.
We next asked whether immune- and stress-related
genes are misregulated in nipi-3(fr4) mutants fed P.
aeruginosa or ToxA, potentially explaining the hypersus-
ceptibility of nipi-3(fr4) to these conditions. Of the 118
codeset genes, 49 were differentially expressed when
comparing nipi-3(fr4) and wild type animals exposed to P.
aeruginosa and 27 were affected in nipi-3(fr4) compared
to wild type when fed ToxA (Additional file 4: Table S3).
In general, genes regulated by nipi-3 were differentially
expressed under multiple conditions (Additional files 4, 5:
Table S3, Figure S2a); for example, 77% of the genes
altered in nipi-3(fr4) on OP50 were also altered in nipi-
3(fr4) on P. aeruginosa. We confirmed the microarray and
NanoString gene expression changes for a subset of genes
using qRT-PCR to analyze wild type and nipi-3(fr4) ani-
mals fed P. aeruginosa, ToxA, or their respective control
bacteria (Additional file 6: Figure S3a, b).
In support of the hypothesis that nipi-3 is an immune
regulator, 44% (156) of the genes up or down regulated in
nipi-3(fr4) animals on control OP50 bacteria were also re-
sponsive to ToxA or the translational inhibitor Hygromycin
B (Additional file 5: Figure S2b; P < 1 × 10–95) as shown by
comparing the current microarray dataset with our previ-
ous characterization of the wild type ToxA/Hygromycin B
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response [5]. In addition, genes differentially expressed in
nipi-3(fr4) fed P. aeruginosa or ToxA compared to wild
type animals on the same food were enriched for patho-
gen-response genes (Additional files 4, 5, 7: Tables S3, Fig-
ure S2c, and Table S4; P < 5 × 10–6). Taken together, these
data demonstrate that nipi-3 is necessary for the proper ex-
pression of immune genes in both unstressed and infected
animals.
ToxA induces defense proteins in wild type but not in
nipi-3(fr4) animals
We next sought to determine the role of NIPI-3 on the
host’s protein response to translational inhibitors since
the extent to which mRNA up or downregulation affects
protein expression under these conditions is unknown.
We performed a large-scale quantitative proteomic ana-
lysis comparing wild type and nipi-3(fr4) animals fed on
ToxA or control BL21 E. coli. This analysis detected a
total of 7535 expressed proteins that map to 7444
unique C. elegans genes, representing approximately half
of the genes expressed in adult animals [21].
We first characterized the protein changes that occur
in wild type animals under translational stress. Of the 50
proteins that significantly changed in wild type upon
ToxA exposure, 40 were upregulated and related to
immunity based on GO term analysis (Additional file 8:
Table S5). The induction of immune-related factors by
ToxA was consistent with our previously published ana-
lysis of ToxA-mediated RNA changes [5]. However, un-
like wild type animals, exposing nipi-3(fr4) mutants to
ToxA caused more proteins to be downregulated than
upregulated, 26 versus 17, respectively (Additional file 8:
Table S5). There was almost no overlap between the
nipi-3(fr4) and wild type responses to ToxA: only one
protein was downregulated in both strains (red arrow,
Fig. 2) and there were no common upregulated proteins.
There were no enriched GO terms among the proteins
up or downregulated by ToxA in nipi-3(fr4) consistent
with the nipi-3(fr4) mutant mounting an uncoordinated,
and ultimately ineffective, response to the toxin.
To directly address the relationship between transcript
and protein changes in the presence of ToxA, we com-
pared the proteomic data to the transcriptional profiling
analysis that we previously performed using the same
ToxA and control strains [5]. Of the 174 transcripts
induced or repressed by ToxA in wild type worms, we
identified 37 corresponding proteins and, of those, 15
(41%) were significantly affected by ToxA (Additional
file 9: Figure S4a). Eight of the 10 RNAs with the highest
ToxA induction were also elevated at the protein level.
Fig. 2 Different proteins are up and downregulated in wild type N2 and nipi-3(fr4) animals following ToxA exposure. Change of protein abundance in
wild type N2 and nipi-3(fr4) animals following 24 hours feeding on E. coli expressing ToxA starting at the L4 stage as compared to animals fed control
BL21 food. Only proteins significantly up or downregulated in wild type N2 and/or nipi-3(fr4) are included. The red arrow points to the only protein
(T15B7.1) significantly altered in both N2 and nipi-3(fr4) animals. Results shown are an average of two biological replicates. Primary data are provided in
Additional file 8: Table S5
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To understand how a protein inhibitor impacts the
relationship between RNA and protein expression, we
performed the same type of analysis using unstressed
conditions lacking translational inhibitors. Specifically,
we analyzed transcriptional and proteomic changes in
nipi-3(fr4) compared to wild type animals fed on control
E. coli (Additional file 10: Table S6) [5]. While 7 of the
10 RNAs with the highest induction in nipi-3(fr4) also
had elevated protein levels, overall, there was less correl-
ation between RNA and protein changes as only 12%
(23/188) of nipi-3(fr4)-affected RNAs showed signifi-
cantly altered protein expression. In addition, there were
39 proteins differentially expressed in nipi-3(fr4) that
were unaffected at the RNA level (Additional file 9:
Figure S4b). One interpretation for the poorer correl-
ation in the nipi-3/wild type control analysis versus the
ToxA/BL21 analysis is that RNAs induced during trans-
lational disruption have less post-transcriptional regula-
tion than RNAs in unstressed conditions. However, a
caveat of the nipi-3 comparison is that different E. coli
strains were used as controls in the transcriptomic and
proteomic analyses (OP50 vs. BL21, respectively).
Intestinal nipi-3 defends against intestinal pathogens
To confer resistance against the intestinal pathogen P.
aeruginosa, nipi-3 must act directly or indirectly in the
intestine. NIPI-3 is expressed in multiple tissues in the
adult C. elegans and was previously shown to function in
the hypodermis but not the intestine to defend against the
hypodermal fungal pathogen D. coniospora [17]. To
determine whether the ToxA response is mediated by
intestinally-expressed NIPI-3 or a systemic signal derived
from hypodermally-expressed NIPI-3 and transported to
the intestine, we knocked down nipi-3 in either the intes-
tine or hypodermis using tissue-specific RNAi C. elegans
strains. We confirmed the tissue-specificity of these strains
with bacterial RNAi clones targeting different tissues. We
did not observe any silencing phenotypes in the gut-
specific RNAi strain for RNAi clones targeting genes in the
hypodermis, body wall muscle, or germline, but we did de-
tect low levels of RNAi silencing in non-hypodermal tis-
sues in the hypodermal-specific RNAi strain (Additional
file 11: Table S7). Knocking down nipi-3 in a gut-specific
RNAi strain made animals hypersusceptible to ToxA and
P. aeruginosa (Fig. 3a top; P < 0.001 for each assay),
whereas knocking down nipi-3 in the hypodermal RNAi
strain did not result in increased ToxA susceptibility com-
pared to control RNAi (Fig. 3a bottom; P > 0.02 for each
assay), even though there was a low level of silencing in
the intestine hypodermal RNAi strain (Additional file 11:
Table S7). To confirm that intestinal nipi-3 is responsible
for the gene expression changes observed in Additional
files 3, 4, and 6: Tables S2, S3, and Figure S3, we per-
formed qRT-PCR of infection-related genes in either wild
type or gut-specific RNAi animals following nipi-3 RNAi.
In both strains, five of the transcripts were upregulated
and six were downregulated (Fig. 3b). Some transcripts
showed a larger difference in wild type animals than in the
gut-specific RNAi strain, which was potentially due to a
difference in RNAi efficiency or indicates nipi-3 has some
activity in a non-gut tissue.
Finally, we tested whether NIPI-3 is also required in
additional tissues by rescuing NIPI-3 only in the intes-
tine of nipi-3(fr4) mutants. Expressing intestinal NIPI-3
was sufficient to rescue the nipi-3(fr4) ToxA defect
(Fig. 3c). Taken together, the data in Fig. 3 show that
intestinal NIPI-3 is both necessary and sufficient to me-
diate C. elegans ToxA defense mechanisms. Importantly,
in contrast to knocking down nipi-3 systemically, remov-
ing nipi-3 only in the intestine did not result in a short-
ened lifespan on control food, and in fact appeared to
enhance the lifespan (Additional file 2: Figure S1c). This
latter experiment emphasizes that the role of nipi-3 in
pathogen defense can be separated from its lifespan and
developmental effects.
Intestinal nipi-3 is not a primary component of known
ToxA-response pathways including PMK-1 p38 or KGB-1
JNK-like MAP kinase
We next asked whether intestinal NIPI-3 is a component
of known immune signaling pathways. Previous work
has shown that, in the hypodermis, NIPI-3 functions up-
stream of the PMK-1 p38 MAPK pathway and between
the protein kinase C TPA-1 and BiP/GRP78 chaperone
HSP-3 [22, 23]. However, unlike nipi-3(fr4) animals,
tpa-1 and hsp-3 mutants had a normal lifespan on ToxA
(Additional file 12: Figure S5; P > 0.4 comparing ToxA
and control E. coli for each strain) indicating that NIPI-3
has different functions in the hypodermis and intestine.
In contrast to hsp-3 and tpa-1, pmk-1 mutants die rap-
idly on ToxA [5] and the mammalian Tribbles homolog
Trib2 is required for p38 phosphorylation in mammalian
cells [24], suggesting that NIPI-3 and PMK-1 may func-
tion together. If NIPI-3 indeed functions solely upstream
of or in conjunction with PMK-1, we reasoned that
PMK-1 phosphorylation levels should be similar in nipi-
3(fr4) animals to the levels observed in sek-1 (MAPKK)
mutants [25]. However, whereas PMK-1 phosphorylation
is apparently decreased in nipi-3(fr4) compared to wild
type worms, it is still present at a significantly higher
level than in a sek-1 mutant (Fig. 4a). We also tested
whether pmk-1 and nipi-3 regulate common down-
stream genes as would be predicted if they are compo-
nents of the same pathway. From our microarray
analysis of animals on control OP50 E. coli, there was al-
most no overlap between nipi-3- and pmk-1-regulated
genes (Fig. 4b); only 5 of the 101 genes downregulated
in nipi-3(fr4) were repressed in pmk-1(km25) and, of the
McEwan et al. BMC Biology  (2016) 14:105 Page 6 of 17
282 genes upregulated in nipi-3(fr4), 3 were upregulated
and 8 were downregulated in pmk-1(km25) (Additional
file 3: Table S2). We additionally analyzed the protein
expression of nipi-3(fr4) and pmk-1(km25) mutants
exposed to ToxA and detected no proteins in common
between the 43 upregulated in nipi-3(fr4) and the 7
Fig. 3 Intestinal nipi-3 expression is necessary and sufficient for resistance against ToxA and P. aeruginosa. a Lifespans of gut or hypodermal RNAi
strains fed E. coli expressing ToxA (left) or P. aeruginosa PA14 (right) following either nipi-3 or L4440 vector control RNAi. P < 0.001 for gut RNAi
assays; P > 0.02 for hyp RNAi assays (log-rank test). b qRT-PCR comparison of L4 animals following nipi-3 RNAi started at the L1 stage. Results
shown are an average of four biological replicates, each normalized to the corresponding wild type L4440 control values. Error bars represent SEM.
*P < 0.05 compared to corresponding wild type animals (Student’s unpaired t-test). c Lifespans of wild type N2, two independent lines of nipi-3(fr4)
expressing intestinal vha-6p::nipi-3, and the non-transgenic offspring of nipi-3(fr4);agEx122 fed E. coli expressing ToxA. Number of animals scored for
each condition was > 50 (373 total; a ToxA), ≥ 145 (656 total; a P. aeruginosa), and ≥ 130 (558 total; c). These are representative experiments of four
(a ToxA), three (a P. aeruginosa), or two (c) independent experiments. Primary data for panel b are provided in Additional file 15
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induced in pmk-1(km25) when comparing each to wild
type worms on ToxA (Additional file 10: Table S6).
Somewhat surprisingly, 16 proteins were repressed in
both nipi-3(fr4) and pmk-1(km25) from a total of 106
pmk-1(km25)-downregulated and 25 nipi-3(fr4)-down-
regulated proteins.
Finally, consistent with NIPI-3 and PMK-1 mediating
separate signaling pathways, we found that animals lack-
ing both nipi-3 and pmk-1 had an increased susceptibil-
ity to ToxA as compared to loss of either protein alone
(Fig. 4c left; P < 0.001 for pmk-1 and pmk-1;nipi-3). A
caveat of this experiment, however, is that the lifespan of
the pmk-1;nipi-3 animals on control food was also short-
ened (Additional file 13: Figure S6a). Taken together, while
there may be some cross-talk between the NIPI-3 and
PMK-1 pathways, our gene expression and pathogen-
susceptibility data are not consistent with a model in
which NIPI-3 functions directly up or downstream of
PMK-1.
We next focused on the KGB-1 JNK-like MAPK path-
way since, like nipi-3, kgb-1 is required for resistance to P.
aeruginosa and acts in parallel to pmk-1 (Fig. 6) [25]. In
addition, mammalian Trib2 has a role in JNK
phosphorylation [24]. While we found that kgb-1 mutants
were hypersusceptible to ToxA, loss of both kgb-1 and
nipi-3 resulted in an additive ToxA effect compared to
loss of either gene alone (Fig. 4c right; P < 0.001 com-
paring kgb-1;nipi-3 and kgb-1 or nipi-3). However, as
with the pmk-1 analysis, the lifespan for kgb-1;nipi-3 on
control E. coli was attenuated compared to loss of only
kgb-1 or nipi-3 (Additional file 13: Figure S6b). Therefore,
we asked whether kgb-1(km21) and nipi-3(fr4) regulate the
same set of downstream genes. We determined that none
of the eight ToxA-response genes assayed by qRT-PCR
were regulated by both kgb-1 and nipi-3 on control E. coli
and ToxA (Additional file 6: Figure S3b), consistent with
KGB-1 and NIPI-3 acting in parallel.
Finally, the bzip transcription factor ZIP-2 and G-protein
coupled receptor FSHR-1 regulate different subsets of
ToxA-response genes and function separately from the
PMK-1 and KGB-1 pathways (Fig. 6) [5]. As was the case
with pmk-1 and kgb-1, there was no overlap between the
transcripts significantly altered in zip-2 or fshr-1 and nipi-3
mutants on control E. coli and P. aeruginosa (Additional
file 6: Figure S3a). In addition, zip-2 and fshr-1 mutants
were much less sensitive to ToxA than nipi-3(fr4)
Fig. 4 NIPI-3 is not immediately up or downstream of PMK-1 p38 MAPK or KGB-1 JNK-like pathways. a Western blot analysis of phosphorylated PMK-1
in L4 animals of the indicated genotype raised on control OP50 E. coli. b Transcript fold changes determined by microarray analysis of nipi-3(fr4) or
pmk-1(km25) animals as compared to wild type N2 raised on OP50 E. coli. Only genes significantly altered in nipi-3(fr4) are shown. c Lifespans of wild
type N2 and pmk-1(km25) (left) or kgb-1(km21) (right) fed E. coli expressing ToxA following either nipi-3 or L4440 vector control RNAi. P< 0.001 comparing
pmk-1 and pmk-1, nipi-3 and comparing kgb-1 and kgb-1; nipi-3 (log-rank test). Number of animals scored for each condition was ≥ 55 (278 total; c right)
and > 90 (424 total; c left). These are representative experiments of two (c left) or three (c right) independent experiments. Primary data for panel b are
provided in Additional file 3: Table S2
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(Additional file 6: Figure S3c; data not shown for fshr-1),
making it unlikely that either ZIP-2 or FSHR-1 are in a
linear pathway with NIPI-3.
nipi-3 genetically interacts with the C/EBP bZIP
transcription factor cebp-1 to promote ToxA resistance
Based on the epistasis analyses, NIPI-3 represents either
the first identified factor of a new signaling pathway
acting in parallel to PMK-1 or it functions to modulate
multiple pathways and coordinate the downstream
effects of different initial inputs. If NIPI-3 represents a
separate branch of immune signaling, we reasoned that
we should be able to identify distinct factors functioning
downstream of nipi-3. To test this, we mutagenized
nipi-3(fr4) animals with EMS and identified 22 mutants
with increased resistance to ToxA (see Methods for
details). We selected two mutants with the strongest
phenotypes from two independent pools for further ana-
lysis. Through whole genome sequencing, we found that
both mutants contained an A246V mutation in the
DNA binding domain of the C/EBP bZIP transcription
factor CEBP-1. When exposed to ToxA or P. aeruginosa,
both the newly-discovered cebp-1(ag33) allele as well as
a previously-isolated cebp-1 deletion allele (tm2807),
completely suppressed the nipi-3(fr4) defect in both in-
fection conditions as compared to wild type animals
(Fig. 5a). However, the single cebp-1 mutants survived
longer on ToxA than wild type worms and the double
cebp-1, nipi-3 mutants were slightly shorter lived on
ToxA than their single cebp-1 mutant counterparts
(Fig. 5a left; P < 0.001) suggesting that nipi-3 may have a
minor additional function in a non-cebp-1 pathway to
protect against ToxA. cebp-1 mutants also suppress the
nipi-3(fr4) lifespan defect as the lifespans of the single
cebp-1 and double cebp-1, nipi-3 mutants were equiva-
lent on control E. coli (Fig. 5b; P > 0.05).
CEBP-1 is expressed in pharyngeal, neuronal and in-
testinal cells [26], and is known to function in neurons
Fig. 5 nipi-3(fr4) survival defects are suppressed by loss of cebp-1 but not loss of pmk-3 or dlk-1. Lifespans of the indicated strains on E. coli
expressing ToxA (a left, c), P. aeruginosa PA14 (a right), or control BL21 E. coli (b). nipi-3(fr4) was used for all assays. cebp-1, dlk-1, and pmk-3 were
inhibited by RNAi in c. Number of animals scored for each condition was > 160 (1178 total; a right), > 140 (1239 total; a left), > 120 (875 total; b),
and > 160 (937 total; c). These are representative experiments of two independent experiments
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during axon regeneration [27]. Therefore, we asked
whether cebp-1 acts in the intestine to mediate ToxA de-
fenses. To test this, we used the gut-specific RNAi strain
described above and compared its susceptibility to ToxA
following knockdown of either nipi-3 or cebp-1 or of
both genes simultaneously. While loss of intestinal
nipi-3 resulted in ToxA hypersusceptibility, animals with
co-knockdown of intestinal nipi-3 and cebp-1 had an
equivalent lifespan on ToxA as those lacking only intes-
tinal cebp-1 (Additional file 14: Figure S7a; for nipi-3,
cebp-1 vs. cebp-1 RNAi, P = 0.95 by log-rank test and 0.4
by Wilcoxon test; for nipi-3 vs. cebp-1 RNAi, P = 0.089 by
long-rank test and 0.0004 by Wilcoxon test), indicating
that CEBP-1 mediates the ToxA defense by functioning in
the intestine.
In neurons, CEBP-1 acts downstream of the DLK-1/
PMK-3 p38 MAPK pathway [27] and so we determined
whether dlk-1 and pmk-3 are also involved in the NIPI-3
intestinal immune pathway. We found that the PMK-3
pathway is not necessary for the ToxA defense since,
unlike RNAi-mediated knockdown of cebp-1, RNAi of
dlk-1 or pmk-3 did not suppress the ToxA sensitivity of
nipi-3(fr4) (Fig. 5c).
Finally, since loss of nipi-3 results in immune gene
misexpression (Additional files 3, 4, 6: Tables S2, S3 and
Figures S3), we tested whether cebp-1 rescues nipi-3’s
pathogen survival phenotype by restoring wild type gene
expression levels during ToxA intoxication. Using qRT-
PCR, we compared wild type animals with single nipi-3
and cebp-1 mutants as well as double nipi-3, cebp-1 mu-
tants. For some genes, such as T24B8.5, the nipi-3(fr4)
defect was partially rescued in the double nipi-3, cebp-1
mutants but, for others, such as F11D11.3, the double
mutants showed stronger misregulation than nipi-3(fr4)
alone (Additional file 14: Figure S7b). A major limitation
of this experiment, however, is that it is unknown which
nipi-3-dependent genes are essential for the ToxA response.
We attempted to identify critical effector proteins acting
downstream of NIPI-3/CEBP-1 by asking whether any of
the individual proteins differentially regulated in nipi-3(fr4)
could account for the pathogen sensitivity of these mutants.
To mimic the defects in nipi-3(fr4), for proteins downregu-
lated in nipi-3(fr4), we knocked down the corresponding
genes by RNAi in wild type worms and assayed for worms
that phenocopied the nipi-3(fr4) ToxA susceptibility. We
similarly inhibited the proteins that were upregulated in
nipi-3(fr4) using RNAi in nipi-3(fr4) mutants and exam-
ined whether these animals survived longer on ToxA.
However, we found no major changes in ToxA sensitivity
following these knockdowns (data not shown).
Discussion
In this study, we find that NIPI-3 is an essential compo-
nent of the C. elegans defense against the translational
inhibitor ToxA as well as P. aeruginosa, the bacterial
pathogen that secretes ToxA. Unlike other previously de-
scribed immune signaling genes, including pmk-1, nipi-3
is upregulated by ToxA. Perhaps counterintuitively, loss of
nipi-3 results in the upregulation of many ToxA-inducible
genes in the absence of translational inhibition. This does
not occur for the ToxA-sensitive pmk-1 mutant in which
immune and stress genes are overall downregulated com-
pared to wild type animals and suggests that NIPI-3 may
have a specialized inhibitory role in responding to transla-
tional inhibitors.
NIPI-3 plays critical roles in both development and im-
munity, analogous to other key innate immune signaling
molecules such as the Toll receptors in Drosophila [28]
and bar-1 β-catenin in C. elegans [29]. While null
mutations in nipi-3 cause animals to arrest by the L3 stage
(Kim et al. http://bmcbiol.biomedcentral.com/articles/
10.1186/s12915-016-0320-z), the use of the fully viable
nipi-3(fr4) hypomorphic allele has allowed us to specific-
ally investigate NIPI-3’s role in pathogen defense. Through
tissue-specific RNAi and rescue experiments, we deter-
mined that NIPI-3-mediated ToxA and P. aeruginosa
defenses are controlled in adult animals by intestinally
expressed nipi-3, consistent with P. aeruginosa being a C.
elegans intestinal pathogen. Previous reports show that
hypodermal but not intestinal expression of nipi-3 is
important for survival against the hypodermal pathogen
D. coniospora [17]. A simple explanation of these data is
that, in late larval stage and adult animals, following the
requirement for NIPI-3 in development, NIPI-3 is only
necessary in the tissue that is under pathogenic attack,
which implies that it functions autonomously to mediate
local immune responses. Alternatively, it is also possible
that intestinally- and hypodermally-expressed nipi-3 regu-
late different immune mechanisms, with the intestinal
responses effective against ToxA-like molecules and the
hypodermal responses effective against distinct pathogenic
mechanisms of D. coniospora. Supporting the hypothesis
that nipi-3 may have unique functions in different tissues,
we show here that the immune signaling molecules hsp-3
and tpa-1, which function in the hypodermal NIPI-3 path-
way [22, 23], are dispensable for mounting ToxA resist-
ance in the intestine, even though, as with nipi-3, they are
expressed in the intestine [30, 31].
In contrast to hsp-3 and tpa-1, pmk-1mutants are hyper-
sensitive to ToxA and the translational inhibitor G418 but
nipi-3 does not appear to function strictly upstream or
downstream of p38 MAPK in response to ToxA. Micro-
array analysis of pmk-1 and nipi-3(fr4) L4 animals, the
stage exposed to ToxA in our standard assay, revealed that
the gene expression signature in these two mutants is re-
markably different on control OP50 bacteria. However,
there may be some interplay between nipi-3 and pmk-1 be-
cause the overall level of activated PMK-1 was reduced in
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L4 nipi-3(fr4) animals. Upon exposure to ToxA, most of
the proteins that changed in the young adult nipi-3(fr4)
mutant animals exhibited an increase over wild type,
whereas the opposite was true for the pmk-1 mutant ani-
mals, where many more proteins were downregulated.
While the majority of overall proteins differentially
expressed in nipi-3(fr4) or pmk-1(km25) on ToxA did not
overlap, a subset of proteins downregulated in nipi-3(fr4)
mutant animals were also reduced in the pmk-1 mutant,
suggesting that either these are a signature of worms dying
from ToxA exposure or there is a commonality in the nipi-
3 and pmk-1 responses to ToxA. However, we argue that
nipi-3 and pmk-1 primarily function in parallel for their
response to the toxin because reduction of nipi-3 activity
by RNAi in the pmk-1 null mutant resulted in increased
hypersusceptibility to ToxA. Interestingly, and in contrast
to our P. aeruginosa data, nipi-3 acts upstream of the p38
MAPK signaling cassette (tir-1/nsy-1/sek-1/pmk-1) in the
hypodermis to regulate the induction of anti-microbial
peptides in response to D. coniospora [17, 22, 32]. In
addition, mutations in the p38 PMK-1 MAPK pathway
suppress nipi-3-dependent developmental arrest and nipi-3
null mutant animals hyperactive PMK-1 at early larval
stages (Kim et al. http://bmcbiol.biomedcentral.com/
articles/10.1186/s12915-016-0320-z). Combining these
studies, it is clear that there are multiple regulatory
interactions between nipi-3 and pmk-1 across different
developmental stages and tissues and these likely con-
tribute to the varied functions of NIPI-3.
For adult nipi-3(fr4) animals exposed to P. aeruginosa
or ToxA, their shortened lifespan can be completely
suppressed by loss of the C/EBP bZIP transcription fac-
tor cebp-1. Removal of cebp-1 does not cause C. elegans
to be hypersusceptible to ToxA, suggesting it normally
functions as a negative regulator. Therefore, the explan-
ation for nipi-3(fr4) lethality on ToxA is that CEBP-1
function is now increased, making NIPI-3 a negative
regulator of CEBP-1 (Fig. 6). In support of this model,
Kim et al. (http://bmcbiol.biomedcentral.com/articles/
10.1186/s12915-016-0320-z) found that cebp-1 transcrip-
tion is increased in the nipi-3 mutant and there is a re-
markable overlap in the gene classes enriched in cebp-1
targets and those repressed by nipi-3, specifically in the
“stress cluster” (Kim et al. http://bmcbiol.biomedcentral.
com/articles/10.1186/s12915-016-0320-z). Finally, other
Tribbles proteins are also known to promote degradation
of target proteins, including MAPKs and C/EBP proteins
[16]. It should be noted that cebp-1 mRNA and protein
Fig. 6 Model of major C. elegans pathways involved in ToxA defenses
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were upregulated in nipi-3(fr4) animals, although these
inductions were not statistically significant.
While the cebp-1 ag33 allele results in a relatively
minor change in CEBP-1, this mutation has been iso-
lated independently at least three times: twice in this
study and once by Bounoutas et al. [33] in a neuronal
mutagenesis screen that identified cebp-1(u819) as a sup-
pressor of the microtubule disrupter colchicine, which
normally causes a general decrease in protein expression
in C. elegans touch receptor neurons. Unlike in our
study, mutations in the PMK-3 p38 MAPK phenocopy
the loss of neuronal cebp-1. For both our study and that
of Bournoutas et al. [33], regardless of the upstream
pathway, CEBP-1 is detrimental to mitigating the effects
of translational inhibitors, either ToxA or colchicine.
Interestingly, another C/EBP transcription factor, cebp-2,
has also recently been shown to play an important role
in C. elegans translational defense. However, unlike
CEBP-1, CEBP-2 promotes ToxA and P. aeruginosa
protective mechanisms by acting as a heterodimeric
transcription factor with ZIP-2 [34]. The ability of CEBP
proteins to both promote and repress protective host
defenses against the same pathogen demonstrates the
range of CEBP immune functions and raises the ques-
tion of whether, for example, CEBP-1 could be a positive
effector under a different condition.
The mechanism by which translational inhibitors acti-
vate the NIPI-3/CEBP-1 pathway remains an open ques-
tion. Dunbar et al. [9] discovered that ZIP-2 accumulation
during a P. aeruginosa infection is mediated by open read-
ing frames in the zip-2 5’UTR (uORFs). This pathogen-
mediated increase in translation is potentially similar to
the response of yeast GCN4 and mammalian ATF4 to
nutritional stresses and translational inhibition [35]. How-
ever, we did not observe uORFs in the nipi-3 5’UTR.
Moreover, proteins induced by ToxA in wild type worms
were not enriched for uORFs, implying that additional ac-
tivation mechanisms must be present. One such strategy
may be linked to transcript abundance; Ivanov and Roy
[13] found that the most abundant transcripts could
bypass the general protein synthesis block caused by L.
pneumophila translational inhibitors. However, a similar
study by Asrat et al. [12] found that translation of the
IL-1β cytokine was independent of its transcript stabil-
ity, suggesting that increasing a transcript’s concentra-
tion is not sufficient to ensure its protein expression.
Another mechanism of post-transcriptional regulation
could be mediated by a second protein such as a labile
repressor that is not synthesized when translation is
disrupted. This is observed at the transcriptional level
in mammalian macrophages when L. pneumophila
translational inhibitors block the production of new
NFκB repressor IκB, resulting in increased gene
expression [10]. It is possible that, if it exists, such a
suppressor could be identified in further C. elegans
screening.
Future studies are also likely to identify additional mecha-
nisms for activating surveillance immune pathways and
may identify strategies employed by the pathogens to sup-
press them. A striking finding from this study is the ap-
proximately 40% correlation between transcript and protein
changes in the worms following ToxA exposure, which is
comparable to other published studies analyzing a variety
of conditions [36] and suggests that, after a 24 hour expos-
ure, ToxA does not globally affect post-transcriptional pro-
cessing. However, ToxA expressed by the P. aeruginosa
strain PA01 is able to broadly reduce C. elegans protein
synthesis [37], which may indicate that P. aeruginosa ex-
presses effectors to inhibit the nematode’s ToxA defense.
Conclusions
We have shown here that nipi-3 enables hosts to survive
pathogen-mediated damage to protein translation. NIPI-3
mediates post-developmental immunity in the intestine by
acting as a negative regulator of the C/EBP transcription
factor CEBP-1, which in turn negatively regulates protect-
ive immune processes. This pathway represents a new
branch of intestinal innate immune signaling.
Methods
Strains
C. elegans were maintained using standard methods. C.
elegans strains used in this study were: N2 (wild type),
IG544 nipi-3(fr4), KU25 pmk-1(km25), MJ563 tpa-1(k530),
RB1104 hsp-3(ok1083), AU0067 kgb-1(km21), RB911
fshr-1(ok778), ERT61 zip-2(tm4248), KU4 sek-1(km4),
MGH167 sid-1(qt9);alxIs6[vha-6p::SID-1::SL2::GFP], JM43
rde-1(ne219);Is[wrt-2p::RDE-1], CZ8920 cebp-1(tm2807),
KU12 dlk-1(km12), BS33830 pmk-3(ok169), and CZ8920
cebp-1(tm2807). The C. elegans strains created for this study
were: AU0329 nipi-3(fr4); agEx119(myo-2p::MCherry,
nipi-3p::NIPI-3), AU0330 nipi-3(fr4);agEx120(myo-




6p::NIPI-3), AU0350 nipi-3(fr4) cebp-1(ag33), AU0352
cebp-1(ag33), and AU0351 nipi-3(fr4) cebp-1(tm2807).
nipi-3p::NIPI-3 was amplified from the fosmid
UBC_f80B0723Q (source bioscience UK limited) with
the primers 5’-TGTTACCTGAAAGTTGCGGA and
5’-CCCGATTCAACTGTTTCAGG. For vha-6p::NIPI-3,
NIPI-3 was amplified from the nipi-3p::NIPI-3 fusion
using the primers 5’- CTAAACTAGTGGGTATGG
CTCGTACAAAATGC and 5’-CCCGATTCAACTGTTT
CAGG and vha-6p was amplified from N2 genomic DNA
with the primers 5’-GATATTGCCAGCATGCTCAACG
and 5’-TCTAGATATGGGTTTTGGTAGGTTTTAGTCG.
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The NIPI-3 and vha-6p fragments were ligated together in
the presence of SpeI, XbaI, and T4 DNA ligase (NEB) and
the expected sized fragment was gel purified with the
QIAquick Gel Extraction kit (Qiagen). Constructs were
injected into worms with the co-injection marker
myo-2p::MCherry, and 1 KB ladder (NEB).
ToxA and BL21 E. coli control (an empty pet100 vec-
tor control) have been previously described [5]. All P.
aeruginosa assays used the clinical isolate PA14 [38].
RNAi clones were obtained from the Ahringer RNAi
library [39] and confirmed by sequencing.
C. elegans lifespan/killing assays
nipi-3 RNAi experiments were started from the L1 stage
and mimicked the survival phenotype of nipi-3(fr4) mu-
tants. All lifespan and killing assays were performed
using the C. elegans Lifespan Machine [15] using worms
and bacteria prepared as described [5], with the modifi-
cation that E. coli plates were incubated for 24 hours at
room temperature before use. All P. aeruginosa ex-
periments utilized full lawn assays. The automated,
high-resolution P. aeruginosa strain PA14 killing assays
required significant modification of the image analysis
software described in [15] to account for the disappear-
ance, or ghosting, of dead animals, the relative opaque-
ness of the PA14 lawn, and a different plate type.
Multiplexed quantitative proteomics
Approximately 10,000 L4 worms were plated per condi-
tion and collected after 24 hours at 25 °C. Worms were
washed with M9, incubated for 15 minutes at room
temperature to remove intestinal bacteria, washed again
and flash frozen in liquid nitrogen. Worms were ground
using a mortar and pestle on dry ice and resuspended in
50 mM HEPES pH 8.5, 3% SDS, and EDTA-free
complete protease-inhibitor (Roche). Samples were spun
down to collect the supernatant. Multiplexed quantita-
tive proteomics was performed using TMT reagents and
an Orbitrap Fusion mass spectrometer applying Simul-
taneous Precursor Selection-MS3 supported quantifica-
tion [40, 41], see below. Differentially regulated proteins
were determined by QSPEC (http://www.nesvilab.org/
qspec.php/; version 1.2.2) [42] using a FDR < 0.05 and
log2(Fold Change) > 0.585 or < –0.585.
For the mass spectrometer analysis, cells were lysed in
a buffer containing 75 mM NaCl, 50 mM HEPES
(pH 8.5), 10 mM sodium pyrophosphate, 10 mM NaF,
10 mM β-glycerophosphate, 10 mM sodium ortho-
vanadate, 10 mM phenylmethanesulfonylfluoride, Roche
Complete Protease Inhibitor EDTA-free tablets, and 3%
sodium dodecyl sulfate. Lysis was achieved by passing
cells 10 times through a 21-gauge needle. Lysates were
further processed through reduction and thiol alkylation
was followed by purifying the proteins using MeOH/
CHCl3 precipitation. Protein digestion was performed
with Lys-C and trypsin. Peptides were labeled with
TMT-10plex reagents (Thermo Scientific) [43] and frac-
tionated by basic pH reversed phase chromatography as
described elsewhere [44]. Multiplexed quantitative prote-
omics was performed on an Orbitrap Fusion mass
spectrometer (Thermo Scientifc) using a Simultaneous
Precursor Selection-based MS3 method [41]. MS2 spec-
tra were assigned using a SEQUEST-based [45] proteo-
mics analysis platform [46]. Based on the target-decoy
database search strategy [47] and employing linear dis-
criminant analysis and posterior error histogram sorting,
peptide and protein assignments were filtered to FDR
of < 1% [46]. Peptides with sequences that were con-
tained in more than one protein sequence from the UniProt
database were assigned to the protein with most matching
peptides [46]. TMT reporter ion intensities were extracted
as that of the most intense ion within a 0.03 Th window
around the predicted reporter ion intensities in the col-
lected MS3 spectra. Only MS3 with an average signal-to-
noise value of larger than 40 per reporter ion as well as
with an isolation specificity [40] of larger than 0.75 were
considered for quantification. A two-step normalization of
the protein TMT-intensities was performed by first nor-
malizing the protein intensities over all acquired TMT
channels for each protein based to the median average
protein intensity calculated for all proteins. To correct for
slight mixing errors of the peptide mixture from each
sample, a median of the normalized intensities was calcu-
lated from all protein intensities in each TMTchannel and
the protein intensities were normalized to the median
value of these median intensities.
Gene expression analyses
Microarray samples were prepared as previously described
[5]. RMA normalized gene expression values were calcu-
lated using the R package ‘affy’ (Release 3.3) [48], while
differential expression analysis was performed with the
package ‘limma’ [49]. NanoString probe hybridization and
data acquisition were performed according to manufac-
turer’s protocols and differentially regulated transcripts
were determined by edgeR [50]. For the microarray and
NanoString analyses, genes were considered differentially
regulated at FDR < 0.05 and log2(Fold Change) > 1 or < –1.
Quantitative RT-PCR was performed and analyzed as
described [5] and P values were determined with an un-
paired, two-tailed Student t-test.
GO term analysis
Data was analyzed through the Gene Ontology Consortium
(www.geneontology.org) [51] [52]. Terms were considered
enriched if P < 1 × 10–3 and Fold Enrichment > 5.
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Immunoblot analysis
L4 worms raised on OP50 were washed with M9 to re-
move bacteria and resuspended in Laemmli sample buffer
(BioRad). Samples were boiled, spun down, and superna-
tants were flash frozen in liquid nitrogen. Proteins were
resolved on a 4–12% Bis-Tris SDS gel, transferred to a
nitrocellulose membrane, and probed with anti-phospho-
PMK-1 (Promega) or anti-actin (Abcam) antibodies.
Larval starvation assay
L1 stage animals were synchronized by hypochlorite
treatment and overnight hatching in M9 at room
temperature. At the indicated day, approximately 100
animals were transferred to NGM plates seeded with
OP50 bacteria and counted. Plates were incubated at
room temperature for 2 or 3 days and scored for growth.
Mutagenesis
Ethyl methane sulfonate mutagenesis of nipi-3(fr4) ani-
mals was carried out using standard methodology [53].
Fortuitously, we found that feeding nipi-3(fr4) on HT115
E. coli expressing vhp-1 RNAi led to early stage larval
arrest, animals were of undetermined developmental age
but not larger than wild type L2 animals, and the
arrested animals subsequently died within several days.
This is in contrast to N2 wild type animals fed the same
vhp-1 RNAi expressing strain that showed delayed devel-
opment compared to the control HT115 L4440 strain
but matured to gravid adults within 2–3 days at 25 °C.
F2 generation eggs from approximately 25,000 muta-
genized nipi-3(fr4) haploid genomes were isolated by
hypochlorite treatment and dropped directly onto vhp-1
RNAi food. Animals were incubated at 25 °C for 2 days
and L4, young adult or gravid adult animals were picked
from the vhp-1 RNAi to standard OP50 E. coli food. The
recovered putative nipi-3 suppressors were re-screened
for sensitivity to ToxA in order to eliminate (1) RNAi
defective mutants and (2) known suppressors of vhp-1,
such as mlk-1, mek-1, kgb-1 [54], and pmk-3 [55], which
have been previously shown to suppress the larval arrest
of vhp-1 mutants but do not suppress the ToxA sensitiv-
ity of nipi-3. For this ToxA secondary test, between 20
and 45 L4 progeny from each putative nipi-3 suppressor
were picked to ToxA and their survival at 25 °C was
followed until all the un-mutagenized nipi-3(fr4) animals
were dead, at which point 100% of N2 wild type animals
were still alive. Two suppressors from independent pools
of mutagenized animals were identified that restored
nipi-3(fr4) mutant animals to wild type levels of ToxA
resistance. Each of the two suppressors was back crossed
to nipi-3(fr4) and at least 50 F2 recombinants which
grew to maturity on vhp-1 RNAi and exhibited wild type
levels of ToxA resistance were pooled for DNA isolation.
The corresponding genetic lesions were identified by
next generation sequencing technology as previously de-
scribed [56]. Methods were modified for sequencing on
Illumina MiSeq according to the manufacturer’s instruc-
tions. The nipi-3(fr4) strain was also sequenced and used
as the reference strain for identification of homozygous
variants. During the process of backcrossing, the nipi-
3(fr4) suppressors were both shown to be X-linked,
which aided in the identification of relevant sequence
variants.
Additional files
Additional file 1: Table S1. Testing whether ToxA-responsive genes
defend against ToxA. This table lists the genes that were previously
found to be significantly induced by E. coli expressing ToxA [5] and were
inhibited either by RNAi or with mutant alleles to determine whether
they are necessary for ToxA resistance. (XLSX 15 kb)
Additional file 2: Figure S1. The ToxA defect of nipi-3(fr4) is not a
result of general strain health. a. Lifespans of nipi-3(fr4) and wild type N2
fed E. coli expressing ToxA or the BL21 control. P < 0.001 comparing
nipi-3(fr4) ToxA and BL21; P > 0.05 comparing N2 ToxA and BL21 (log-rank
test). b. Fraction of nipi-3(fr4) or wild type N2 animals that grow within 2 or
3 days of being fed OP50 following starvation at room temperature for the
indicated time. Results shown are an average of six biological replicates.
Error bars represent SD. c. Lifespans of wild type N2 and MGH167 (gut RNAi)
animals fed on BL21 control E. coli following either nipi-3 or L4440 vector
control RNAi. Number of animals scored for each condition was > 65 (286
total; a) and > 65 (332 total; c). These are representative experiments of four
(a), three (c), or two (b) independent experiments. (PDF 435 kb)
Additional file 3: Table S2. Affymetrix microarray analysis of wild type
N2, nipi-3(fr4), and pmk-1(km25) gene expression. This table lists the
genes differentially expressed in wild type N2 and nipi-3(fr4) (first tab) or
pmk-1(km25) (second tab) animals fed control OP50 E. coli at 20 °C until
the L4 stage. Expression values are the average of three independent
replicates. Gene ontology terms enriched in each category are listed in
the third tab. (XLSX 59 kb)
Additional file 4: Table S3. NanoString analysis of wild type N2 and
nipi-3(fr4) gene expression. This table lists the gene expression fold
changes between wild type N2 and nipi-3(fr4) animals fed P. aeruginosa
PA14 or control OP50 E. coli for 6 hours (first tab) or fed E. coli expressing
ToxA or BL21 control for 24 hours (second tab). Expression values are the
average of three (PA14 and OP50) or two (ToxA and BL21 control)
independent replicates and normalized to three control genes. Primary
data are provided in Additional file 15. (XLSX 33 kb)
Additional file 5: Figure S2. Genes differentially expressed in nipi-3(fr4)
are enriched for translational inhibitor- and pathogen-response genes. a.
Overlaps between genes differentially expressed in nipi-3(fr4) versus wild
type animals fed the indicated food. Numbers provided for major overlap
classes. b. Overlap between genes differentially expressed in nipi-3(fr4) versus
wild type animals fed control OP50 E. coli and genes induced/repressed
by ToxA or hygromycin versus control bacteria in wild type animals [5].
P < 1 × 10–95 (hypergeometric test). c. Overlap between genes differentially
expressed in nipi-3(fr4) versus wild type animals fed P. aeruginosa or ToxA
and genes induced/repressed by P. aeruginosa or ToxA versus control
bacteria in wild type animals P < 5 × 10–6 (hypergeometric test). Data
collected from microarray (b) or NanoString (a, c) analyses. Primary data for
panels a and c are provided in Additional file 15. (PDF 403 kb)
Additional file 6: Figure S3. Lifespan and gene expression analysis of
nipi-3(fr4) and mutants of other immune pathways required for the ToxA
response. a. qRT-PCR comparison of wild type N2, nipi-3(fr4), pmk-1(km25),
zip-2(tm4248), and fshr-1(ok778) animals following exposure to P. aeruginosa
PA14 or OP50 E. coli for 6 hours. Results shown are an average of two
(fshr-1) or three (remaining samples) biological replicates. b. qRT-PCR
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comparison of wild type N2, nipi-3(fr4), and kgb-1(km21) animals following
exposure to E. coli expressing ToxA or the BL21 control for 24 hours. Results
shown are an average of two biological replicates. For a and b, results are
normalized to the value of wild type worms on control E. coli for the given
gene. Error bars represent SEM. *P < 0.05 (Student’s t-test) when compared
to the corresponding wild type animals. c. Lifespans of wild type N2,
pmk-1(km25), zip-2(tm4248), and nipi-3(RNAi) fed E. coli expressing ToxA.
Number of animals scored for each condition was ≥ 55 (257 total). This
is a representative experiment of three independent experiments.
Primary data for panels a and b are provided in Additional file 15.
(PDF 463 kb)
Additional file 7: Table S4. NanoString analysis of wild type N2 gene
expression on P. aeruginosa or ToxA. This table lists the gene expression
fold changes between wild type N2 animals fed P. aeruginosa PA14 and
animals fed control OP50 E. coli for 6 hours or between N2 animals fed E.
coli expressing ToxA and animals fed the BL21 control for 24 hours.
Expression values are the average of three (PA14 and OP50) or two (ToxA
and BL21 control) independent replicates and normalized to three control
genes. Primary data are provided in Additional file 15. (XLSX 22 kb)
Additional file 8: Table S5. ToxA-induced protein changes. This table lists
the proteins differentially expressed in wild type N2 (first tab) or nipi-3(fr4)
(second tab) animals fed E. coli expressing ToxA or the BL21 control for
24 hours. Relative expression levels are an average of two independent
replicates. Primary data are provided (third tab). (XLSX 1584 kb)
Additional file 9: Figure S4. Comparing RNA and protein changes in
animals exposed to ToxA or control bacteria. Changes of protein and
RNA abundances in wild type N2 animals following a 24 hour exposure
to E. coli expressing ToxA as compared to animals fed a control BL21 E.
coli (top) or in nipi-3(fr4) animals fed control bacteria as compared to
similarly treated wild type animals (bottom). Only values with significant
protein and/or RNA changes are included. Results shown are an average
of two (protein) or three (RNA) biological replicates. Primary data are
provided in Additional file 8: Table S5. (PDF 423 kb)
Additional file 10: Table S6. Proteins misregulated in nipi-3(fr4) or
pmk-1(km25) as compared to wild type worms. This table lists the
proteins differentially expressed in wild type N2 and nipi-3(fr4) animals
fed BL21 control bacteria (first tab) or E. coli expressing ToxA (second tab)
for 24 hours. This table also lists the proteins differentially expressed in
wild type N2 and pmk-1(km25) animals fed E. coli expressing ToxA for
24 hours (third tab). Relative expression levels are an average of two
independent replicates. Primary data are provided in Additional file 8.
(XLSX 29 kb)
Additional file 11: Table S7. Specificity of tissue-restricted RNAi strains.
This table lists the results of RNAi feeding experiments using double
stranded RNAs targeting genes expressed in the indicated tissue. Results
presented as percentage of affected animals and the total number
scored. Synchronized L1 worms were dropped onto the RNAi food and,
after 3 days, worms were scored as affected if they developmentally
arrested (act-5), twitched in 10 mM levamisole (unc-22), had a detached
cuticle (bli-1), low mobility (unc-45), sterility (pos-1) or any of the previous
phenotypes (L4440 control). (XLSX 10 kb)
Additional file 12: Figure S5. Hypodermal immune genes tpa-1 and
hsp-3 are not hypersusceptible to ToxA. Lifespans of tpa-1(k530) and
hsp-3(ok1083) fed on E. coli expressing ToxA or the BL21 control. Number
of animals scored for each condition was > 45 (280 total). This is a
representative experiment of four independent experiments. (PDF 360 kb)
Additional file 13: Figure S6. Loss of nipi-3 and pmk-1 or kgb-1 results
in a shortened lifespan on control food. Lifespans of pmk-1(km25),
pmk-1(km25);nipi-3(RNAi) (a) or kgb-1(km21), kgb-1(km21);nipi-3(RNAi)
(b) and nipi-3(RNAi) fed on BL21 control E. coli. Number of animals scored
for each condition was ≥ 160 (482 total; a) and ≥ 140 (381 total; b).
These are representative experiments of two independent experiments.
(PDF 388 kb)
Additional file 14: Figure S7. cebp-1 acts in the intestine and affects
immune gene expression. a. Lifespans of MGH167 (gut RNAi) animals
grown on equal mixtures of cebp-1 RNAi and L4440 vector control; nipi-3
RNAi and L4440 vector control; cebp-1 and nipi-3 RNAi; or L4440 vector
control alone to the L4 stage. Animals were then transferred to E. coli
expressing ToxA. Note that the mixed nipi-3 RNAi showed less ToxA
susceptibility than undiluted nipi-3 RNAi (Fig. S1b). P = 0.95 (log-rank test)
and 0.4 (Wilcoxon test) for nipi-3, cebp-1 versus cebp-1 RNAi; P = 0.089
(log-rank test) and 0.0004 (Wilcoxon test) for nipi-3 versus cebp-1 RNA.
Number of animals scored for each condition was > 65 (426 total). This is
a representative experiment of two independent experiments. b. qRT-PCR
comparison of the indicated strains exposed to E. coli expressing ToxA for
24 hours. Results shown are an average of two biological replicates and
are normalized to the corresponding wild type ToxA value. Error bars
represent SEM. nipi-3 refers to nipi-3(fr4). Primary data for panel b are
provided in Additional file 15. (PDF 206 kb)
Additional file 15: Primary data for Figs. 1b and 3b, Figures S3a, b, and
S7b, and Tables S3 and S4. (XLSX 35 kb)
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